Aquestive Therapeutics
AQST
AQST
60 hedge funds and large institutions have $96.5M invested in Aquestive Therapeutics in 2020 Q3 according to their latest regulatory filings, with 15 funds opening new positions, 22 increasing their positions, 16 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
4.02% more ownership
Funds ownership: 55.13% → 59.15% (+4%)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
79% less call options, than puts
Call options by funds: $270K | Put options by funds: $1.32M
Holders
60
Holding in Top 10
2
Calls
$270K
Puts
$1.32M
Top Buyers
| 1 | +$3.05M | |
| 2 | +$2.85M | |
| 3 | +$618K | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$615K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$588K |
Top Sellers
| 1 | -$1.38M | |
| 2 | -$942K | |
| 3 | -$756K | |
| 4 |
Millennium Management
New York
|
-$749K |
| 5 |
BBVA
Banco Bilbao Vizcaya Argentaria
Madrid,
Spain
|
-$196K |